Clinical Trial Update: Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.

View source ↗

Summary

A recruiting clinical trial at Hospital General Universitario Gregorio Marañon is evaluating the BMPR2-Activin signaling pathway in Group II pulmonary hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Pulmonary Hypertension
• Pulmonary Hypertension Due to Left Heart Disease

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension (PH) | Status: RECRUITING